Global youth ischemic heart disease and stroke burden

Ischemic heart disease and ischemic stroke in adolescents and young adults have outsized lifetime consequences, given decades of potential life lost and long-term functional impairment. The latest comparative estimates from the Global Burden of Disease platform assemble mortality, morbidity, and risk attribution signals for ages 15-39 years across the period 1990-2021. The analysis captures deaths, years of life lost, years lived with disability, and disability-adjusted life years to describe burden at global, regional, and national levels. It also disaggregates by 5-year age bins and sex, enabling a more granular view of early cardiovascular risk. For health systems prioritizing prevention, these data point to where burden concentrates and which modifiable exposures matter most in youths.

Scope and methods

The comparative framework spans two causes relevant to early cardiovascular outcomes: ischemic heart disease and ischemic stroke. Cause-of-death estimates are synthesized from vital registration, verbal autopsy, and surveillance sources, using standardized models to harmonize heterogeneous inputs. Nonfatal outcomes are mapped to case definitions and sequelae, with severity distributions informing YLDs. DALYs sum YLLs and YLDs, providing a composite measure that captures both premature mortality and disability. The risk attribution component follows a comparative risk assessment approach, estimating the proportion of cause-specific burden attributable to exposure distributions relative to a theoretical minimum risk exposure level.

Case definitions and outcomes

Ischemic heart disease includes clinical presentations attributable to coronary atherosclerosis and related thrombotic events, while ischemic stroke reflects cerebral infarction due to vascular occlusion. Outcomes include death counts, mortality rates, nonfatal prevalence, YLLs, YLDs, and DALYs. Age-standardized rates are used to compare across locations with different demographic structures, and stratifications by sex and 5-year age groups reveal gradients within the 15-39-year range. For clinicians, DALYs contextualize disability during schooling, workforce entry, and childbearing years, emphasizing the societal impact beyond hospital metrics. The inclusion of both fatal and nonfatal endpoints underscores the need for comprehensive strategies that span acute care and long-term secondary prevention.

Temporal trends 1990 to 2021

Over 1990-2021, demographic growth, aging within the youth bracket, and shifting exposures have altered the absolute and relative burden profiles. Age-standardized trends provide a clearer view of epidemiologic change, helping to separate true risk dynamics from population growth. Patterns in deaths and DALYs among ages 15-39 highlight where early-onset atherosclerotic disease persistently contributes to premature mortality and where nonfatal stroke outcomes shape disability. Interpreting these trends requires attention to data density and model uncertainty across regions, especially where vital registration is sparse. Even with uncertainty, the comparative lens enables consistent, policy-relevant comparisons through time and place.

Comparative risk factors across regions

The risk factor component quantifies how metabolic, behavioral, and environmental exposures contribute to ischemic heart disease and ischemic stroke in youths. Metabolic exposures typically include elevated blood pressure, LDL cholesterol, high body mass index, and impaired glucose homeostasis. Behavioral exposures encompass tobacco use, diet quality, and physical activity patterns, while environmental exposures include ambient particulate matter pollution. By anchoring to a theoretical minimum risk exposure, the analysis estimates population attributable fractions and converts them into risk-attributable deaths and DALYs. Location-specific exposure distributions and exposure-response functions drive heterogeneity in attributable burden across countries and regions.

Behavioral and metabolic risks in youths

In early life, cardiometabolic risk often presents as clustered exposures that track into adulthood, making youth a critical window for prevention. Elevated blood pressure and dyslipidemia are measurable and modifiable, yet detection gaps remain in primary care for adolescents and young adults. Diet patterns high in sodium and trans fats, low in whole grains and fruits, and sedentary time contribute to cardiometabolic profiles that raise atherothrombotic risk. The comparative framework quantifies the fraction of ischemic heart disease and ischemic stroke attributable to these exposures within the 15-39 age range. Identifying high-impact behavior and metabolic targets enables integrated interventions across schools, workplaces, and community health platforms.

Environmental and occupational exposures

Ambient air pollution is a relevant exposure for youths, particularly fine particulate matter that amplifies atherosclerotic and thrombotic pathways. Urbanization patterns and fuel use influence exposure distributions, which in turn shape attributable cardiovascular DALYs in younger populations. Occupational exposures may enter earlier for youths in certain settings, adding to cumulative risk, though the mix and intensity vary widely by country and sector. Incorporating environmental and occupational risks into the comparative framework ensures a more complete picture of modifiable contributors beyond individual behaviors. For policy makers, this highlights the synergy between clinical prevention and clean-air or worker-protection policies.

Regional and national heterogeneity

Geographic differences in burden and risk attribution are substantial in this age group, reflecting variation in exposures, health system capacity, and baseline cardiovascular risk. Locations with higher cardiometabolic exposure prevalence, lower access to primary prevention, or rapid urbanization can show elevated attributable fractions for ischemic heart disease and stroke. The Socio-demographic Index offers a lens to interpret patterns across development gradients, but outliers are common due to unique policy, genetic, or cultural contexts. Age-standardized comparisons help reveal true gradients in risk and outcomes irrespective of population size and structure. These cross-country contrasts are valuable for benchmarking prevention performance and prioritizing resource allocation.

Measuring change and uncertainty

Interpreting comparative risk results requires attention to uncertainty intervals that reflect input data quantity, measurement error, and model structure. Locations with sparse vital registration or nonfatal data typically have wider uncertainty, which should temper interpretation of small differences or short-term fluctuations. At the same time, consistent directional patterns across multiple risk factors and outcomes can provide robust signals even when precise ranks vary. Presenting uncertainty alongside point estimates supports transparent communication with clinicians and policy stakeholders. It also clarifies where additional surveillance or registry investments would most improve decision-making.

Implications for practice and policy

For clinicians, the youth burden of ischemic heart disease and ischemic stroke underscores the need to integrate cardiovascular risk detection into routine care for ages 15-39. Opportunistic screening for blood pressure, lipids, glycemic status, nicotine exposure, and physical activity can be offered in primary care, sexual health services, student clinics, and workplace health programs. Counseling should emphasize achievable dietary shifts, activity targets, and cessation support, with pharmacotherapy considered for high-risk profiles according to guideline thresholds. Early identification of familial dyslipidemia and other inherited risks can prevent catastrophic events in the third and fourth decades. The composite DALY lens highlights the value of preventing both fatal events and disabling nonfatal outcomes in adolescence and early adulthood.

Clinical prevention checkpoints

Embedding cardiovascular checkpoints into routine youth encounters can close detection gaps. Practical steps include measuring blood pressure at every visit, lipid testing in late adolescence or earlier if red flags exist, and screening for nicotine use including vaping. Lifestyle counseling is most effective when tailored and reinforced longitudinally, with referrals to dietetics, exercise programs, and cessation resources as indicated. Where therapeutic thresholds are met, statins, antihypertensives, and glucose-lowering agents should be used thoughtfully, balancing long-term benefit and safety in younger patients. Documentation and follow-up infrastructure are critical to maintain momentum across transitions between pediatric and adult care.

Population health and policy levers

Population-level strategies amplify clinical prevention by shifting exposure distributions. Tobacco taxation, smoke-free laws, sodium reduction policies, front-of-pack labeling, and trans-fat elimination reduce population risk with broad reach. Clean-air regulations, especially those targeting fine particulate matter, can lower cardiovascular mortality and morbidity attributable to ambient pollution. School and workplace environments that promote healthy food choices and physical activity enable durable behavior change. These levers operate upstream of the clinic, complementing individualized care and improving equity by reaching youths who have limited healthcare access.

Equity and young people

Cardiovascular prevention in youths must account for social determinants that shape exposure and access to care. Food environments, marketing, neighborhood safety, transportation, and occupational conditions all influence risk accumulation before age 40. Policies that reduce financial and logistical barriers to screening and counseling, alongside smoke-free housing and safer streets for active transport, can hasten progress. Equity-focused strategies also include culturally adapted communication and community partnerships that resonate with adolescents and young adults. Measuring progress with disaggregated indicators helps ensure that gains are shared across groups and places.

Metrics and program evaluation

Program success should be tracked with proximal and distal indicators aligned to the comparative framework. Proximal measures include prevalence of elevated blood pressure, LDL cholesterol, tobacco use, and physical inactivity among 15-39-year-olds. Distal indicators include changes in age-standardized mortality, YLLs, YLDs, and DALYs from ischemic heart disease and ischemic stroke. Linking clinical registries, population surveys, and environmental monitoring improves attribution and guides course correction. Transparent reporting, including uncertainty intervals, supports learning health systems and facilitates cross-country benchmarking.

Data gaps and research needs

Despite progress, data gaps remain, particularly in settings without robust vital registration, stroke registries, or repeated risk factor surveys. Enhancing case validation for ischemic stroke subtypes, harmonizing coding across systems, and improving outpatient data capture will sharpen YLD estimates in youths. Research should prioritize intervention trials and implementation studies tailored to adolescents and young adults, including digital engagement and school or workplace delivery models. Methodologic advances that integrate wearable data, air quality sensors, and longitudinal cohorts could strengthen exposure assessment and temporality. Investments in routine data systems will reduce uncertainty and accelerate policy-relevant insight.

Taken together, the youth burden of ischemic heart disease and ischemic stroke over 1990-2021 highlights a crucial prevention window with high lifetime returns. The comparative framework clarifies which exposures are most actionable and where geographic disparities persist, informing clinical, public health, and policy responses. While uncertainty varies across settings, the direction of effect for modifiable cardiometabolic and behavioral risks is consistent with long-standing evidence. Next steps include scaling youth-focused prevention in clinical workflows, aligning population policies to shift exposures, and strengthening data systems to track equitable progress.